KR20220113437A - 핵산 조성물 - Google Patents

핵산 조성물 Download PDF

Info

Publication number
KR20220113437A
KR20220113437A KR1020227022670A KR20227022670A KR20220113437A KR 20220113437 A KR20220113437 A KR 20220113437A KR 1020227022670 A KR1020227022670 A KR 1020227022670A KR 20227022670 A KR20227022670 A KR 20227022670A KR 20220113437 A KR20220113437 A KR 20220113437A
Authority
KR
South Korea
Prior art keywords
construct
expression cassette
dsrna
promoter
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227022670A
Other languages
English (en)
Korean (ko)
Inventor
제임스 로빈스 앱샤이어
히만슈 다만카르
윌리엄 파머
크리스토퍼 그레그
Original Assignee
그린라이트 바이오사이언시스, 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 그린라이트 바이오사이언시스, 아이엔씨. filed Critical 그린라이트 바이오사이언시스, 아이엔씨.
Publication of KR20220113437A publication Critical patent/KR20220113437A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • C12N2330/51—Specially adapted vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/34—Vector systems having a special element relevant for transcription being a transcription initiation element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
KR1020227022670A 2019-12-06 2020-12-04 핵산 조성물 Pending KR20220113437A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962944824P 2019-12-06 2019-12-06
US62/944,824 2019-12-06
PCT/US2020/063490 WO2021113774A1 (en) 2019-12-06 2020-12-04 Nucleic acid compositions

Publications (1)

Publication Number Publication Date
KR20220113437A true KR20220113437A (ko) 2022-08-12

Family

ID=74046190

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227022670A Pending KR20220113437A (ko) 2019-12-06 2020-12-04 핵산 조성물

Country Status (10)

Country Link
US (1) US20220411792A1 (https=)
EP (1) EP4069843A1 (https=)
JP (1) JP2023505188A (https=)
KR (1) KR20220113437A (https=)
CN (1) CN115397982A (https=)
AU (1) AU2020395244A1 (https=)
CA (1) CA3163345A1 (https=)
CL (1) CL2022001481A1 (https=)
MX (1) MX2022006748A (https=)
WO (1) WO2021113774A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12077763B2 (en) 2021-03-08 2024-09-03 Greenlight Biosciences, Inc. RNA-based control of powdery mildew
MX2023012833A (es) * 2021-04-30 2024-01-23 Greenlight Biosciences Inc Opciones terapéuticas y composiciones de arn mensajero.
TW202306573A (zh) * 2021-05-26 2023-02-16 比利時商ｅＴｈｅＲＮＡ免疫治療公司 減少雙股ｒｎａ副產物形成的方法
CN121889507A (zh) * 2023-08-29 2026-04-17 南京金斯瑞生物科技有限公司 用于非b型dna序列的克隆/表达载体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822164B1 (fr) * 2001-03-19 2004-06-18 Centre Nat Rech Scient Polypeptides derives des arn polymerases, et leurs utilisations
WO2005040388A2 (en) * 2003-08-22 2005-05-06 Nucleonics Inc. Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments
RU2420584C1 (ru) * 2009-10-29 2011-06-10 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Лентивирусная репортерная векторная система для измерения активности ключевых транскрипционных факторов, отражающих функциональное состояние сигнальных путей клетки
US9254311B2 (en) * 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
BR112020007068A2 (pt) 2017-10-11 2020-10-06 Greenlight Biosciences, Inc. métodos e composições para produção de nucleosídeo trifosfato e ácido ribonucleico
AU2020253354A1 (en) * 2019-03-29 2021-10-28 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid

Also Published As

Publication number Publication date
CL2022001481A1 (es) 2023-03-17
EP4069843A1 (en) 2022-10-12
CA3163345A1 (en) 2021-06-10
MX2022006748A (es) 2023-01-19
WO2021113774A1 (en) 2021-06-10
AU2020395244A1 (en) 2022-06-16
US20220411792A1 (en) 2022-12-29
JP2023505188A (ja) 2023-02-08
CN115397982A (zh) 2022-11-25

Similar Documents

Publication Publication Date Title
US20250084397A1 (en) Methods of purifying dna for gene synthesis
KR20220113437A (ko) 핵산 조성물
JP6125493B2 (ja) 転写終結配列
CN112877327B (zh) 基于crispr的组合物和使用方法
US9528137B2 (en) Methods for cell-free protein synthesis
CN116096876A (zh) Ii类v型crispr系统
EP3204513A2 (en) Crispr oligonucleotides and gene editing
RS61262B1 (sr) Novi postupci za proizvodnju oligonukleotida
JP2013520158A (ja) タンパク質生産の増強のためのｍＲＮＡの一次構造の再操作
JP7209700B2 (ja) ホスホロチオエート化したヌクレオチドを含む二本鎖鎖状体ｄｎａを使用するインビボｒｎａ又はタンパク質発現
US20260078437A1 (en) Cell-free method of producing synthetic circular nucleic acid
KR20230134409A (ko) 관심 rna 및/또는 유용물질의 생산을 위한 세포, 전사-번역을 하는 시스템 및 rna 전사시스템, 그리고 이들의 방법 및 생산물
KR20230134413A (ko) 관심 rna 및/또는 유용물질의 생산을 위한 세포, 무세포 시스템 및 rna 전사시스템, 그리고 이들의 방법 및 생산물
CN117813379A (zh) 包括crispr核酸酶的基因编辑系统和其用途
US9944966B2 (en) Method for production of single-stranded macronucleotides
US20180291066A1 (en) In vivo production of long double stranded rna utilizing vlps
KR20240020179A (ko) 관심 rna 및/또는 유용물질의 생산을 위한 세포, 무세포 시스템 및 rna 전사시스템, 그리고 이들의 방법 및 생산물
WO2025207837A1 (en) Viral mrna capping enzyme and methods of use thereof
Curry Platform technology for the enhanced manufacture and utilisation of synthetic mRNA
WO2026050151A1 (en) Rna polymerases for mrna manufacturing
WO2024211833A2 (en) Methods and compositions for nucleic acid synthesis
Bernhardt et al. Transfer RNA as a potential building block for nanotechnology

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000